Original Article

You have full text access to this OnlineOpen article

Response to low-dose ketoconazole and subsequent dose escalation to high-dose ketoconazole in patients with androgen-independent prostate cancer

  1. Mari Nakabayashi MD, PhD1,
  2. Wanling Xie MS2,
  3. Meredith M. Regan ScD2,
  4. David M. Jackman MD1,
  5. Philip W. Kantoff MD1,
  6. William K. Oh MD1,†,*

Article first published online: 21 JUL 2006

DOI: 10.1002/cncr.22085

Issue

Cancer

Cancer

Volume 107, Issue 5, pages 975–981, 1 September 2006

Additional Information

How to Cite

Nakabayashi, M., Xie, W., Regan, M. M., Jackman, D. M., Kantoff, P. W. and Oh, W. K. (2006), Response to low-dose ketoconazole and subsequent dose escalation to high-dose ketoconazole in patients with androgen-independent prostate cancer. Cancer, 107: 975–981. doi: 10.1002/cncr.22085

Author Information

  1. 1

    Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts

  2. 2

    Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts

  1. †

    Fax: (617) 632-2165

*Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney St., Boston, MA 02115

Publication History

  1. Issue published online: 21 AUG 2006
  2. Article first published online: 21 JUL 2006
  3. Manuscript Accepted: 9 MAY 2006
  4. Manuscript Revised: 12 APR 2006
  5. Manuscript Received: 9 FEB 2006

Funded by

  • C. Brendan Noonan Charitable Foundation
  • Bing Sound Wong Fund for Prostate Cancer Research

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (92K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Bing-Juin Chiang, Yeong-Shiau Pu, Hong-Jeng Yu, Chao-Yuan Huang, Ketoconazole in Taiwanese castration-resistant prostate cancer patients: Evaluation of response rates, durations, and predictors, Urological Science, 2012,

    CrossRef

  2. 2
    David R. Yates, Morgan Rouprêt, Comparing how significantly the pharmacological treatment of genitourinary cancer in a non-curative setting affects endpoints of survival or response, World Journal of Urology, 2011,

    CrossRef

  3. 3
    Tadas S. Vasaitis, Robert D. Bruno, Vincent C.O. Njar, CYP17 inhibitors for prostate cancer therapy, The Journal of Steroid Biochemistry and Molecular Biology, 2011, 125, 1-2, 23

    CrossRef

  4. 4
    Giuseppe Procopio, Valentina Guadalupi, Maria Olga Giganti, Luigi Mariani, Roberto Salvioni, Nicola Nicolai, Filippo Capone, Riccardo Valdagni, Emilio Bajetta, Low dose of ketoconazole in patients with prostate adenocarcinoma resistant to pharmacological castration, BJU International, 2011, 108, 2
    Direct Link:
  5. 5
    Guo-Wen Lin, Xu-Dong Yao, Ding-Wei Ye, LOW DOSE OF KETOCONAZOLE IN PATIENTS WITH PROSTATE ADENOCARCINOMA RESISTANT TO PHARMACOLOGICAL CASTRATION, BJU International, 2011, 107, 8
    Direct Link:
  6. 6
    Neeraj Agarwal, Nicholas J. Vogelzang, SECONDARY HORMONAL MANIPULATIONS IN THE TREATMENT OF CASTRATION REFRACTORY PROSTATE CANCER, BJU International, 2011, 108, 2
    Direct Link:
  7. 7
    Mari Nakabayashi, Lillian Werner, William K. Oh, Meredith M. Regan, Philip W. Kantoff, Mary-Ellen Taplin, Secondary Hormonal Therapy in Men With Castration-Resistant Prostate Cancer, Clinical Genitourinary Cancer, 2011, 9, 2, 95

    CrossRef

  8. 8
    Mari Nakabayashi, William K. Oh, Susanna Jacobus, Meredith M. Regan, Mary-Ellen Taplin, Philip W. Kantoff, Jonathan E. Rosenberg, Activity of ketoconazole after taxane-based chemotherapy in castration-resistant prostate cancer, BJU International, 2010, 105, 10
    Direct Link:
  9. 9
    Caroline P. Owen, Imran Shahid, Wai-Yee Lee, Sabbir Ahmed, Synthesis and biochemical evaluation of a range of (4-substituted phenyl)sulfonate derivatives of 4-hydroxybenzyl imidazole-based compounds as potent inhibitors of 17α-hydroxylase/17,20-lyase (P45017α) derived from rat testicular microsomes, Bioorganic & Medicinal Chemistry Letters, 2010, 20, 17, 5345

    CrossRef

  10. 10
    Kelly J. Boudreaux, Sam S. Chang, Treating asymptomatic patients with hormone-refractory prostate cancer: hormonal manipulations for the urologist, BJU International, 2008, 101, 6
    Direct Link:
  11. 11
    William L. Casley, Carolina Ogrodowczyk, Louise Larocque, Bozena Jaentschke, Carole LeBlanc-Westwood, J. Allan Menzies, Larry Whitehouse, Mary Alice Hefford, Rémy A. Aubin, Caroline F. Thorn, Alexander S. Whitehead, Xuguang Li, Cytotoxic Doses of Ketoconazole Affect Expression of a Subset of Hepatic Genes, Journal of Toxicology and Environmental Health, Part A, 2007, 70, 22, 1946

    CrossRef

  12. 12
    Hesham M. Korashy, Dion R. Brocks, Ayman O.S. El-Kadi, Induction of the NAD(P)H:quinone oxidoreductase 1 by ketoconazole and itraconazole: A mechanism of cancer chemoprotection, Cancer Letters, 2007, 258, 1, 135

    CrossRef

  13. 13
    Vânia M.A. Moreira, Tadas S. Vasaitis, Vincent C.O. Njar, Jorge A.R. Salvador, Synthesis and evaluation of novel 17-indazole androstene derivatives designed as CYP17 inhibitors, Steroids, 2007, 72, 14, 939

    CrossRef

  14. 14
    Robert D. Bruno, Vincent C.O. Njar, Targeting cytochrome P450 enzymes: A new approach in anti-cancer drug development, Bioorganic & Medicinal Chemistry, 2007, 15, 15, 5047

    CrossRef

View Full Article (HTML) Get PDF (92K)